Modulatory effects of human herpes virus-7 on cytokine synthesis and cell proliferation in human peripheral blood mononuclear cell cultures

Journal of Leukocyte Biology

Volumn 66, Issue 5, 1999, Pages 822-828

  Atedzoé, Blanche Ngola ^b   Menezes, José ^b   D'Addario, Mario ^b   Xu, Jingwu ^b   Ongradi, Joseph ^b   Ahmad, Ali ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b NONE

Author keywords

Interferon ; Transforming growth factor ; Tumor necrosis factor

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

CELL PROLIFERATION; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DOWN REGULATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 7; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE PROLIFERATION; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; VIRUS INFECTION; VIRUS REACTIVATION;

ALPHAVIRUS; DNA VIRUSES; HERPES; HERPES VIRUS 7; HERPESVIRIDAE; HERPESVIRUS 7; HUMAN HERPES VIRUS; HUMAN HERPES VIRUS 7; HUMAN HERPESVIRUS 7;

EID: 0003735670     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1002/jlb.66.5.822     Document Type: Conference Paper

References (46)

1. + T cells. Proc. Natl. Acad. Sci. USA 87, 748-752.
2. Ablashi, D. V. (1994) Viral studies of chronic fatigue syndrome. Clin. Infect. Dis. 18 (Suppl. 1), S130-S133.
3. Sairenji, T., Yamanishi, K., Tachibana, Y., Bertoni, G., Kurata, T. (1995) Antibody responses to Epstein-Barr virus, human herpesvirus 6 and human herpesvirus 7 in patients with chronic fatigue syndrome. Intervirol. 38, 269-273.
4. Tanaka, K., Kondo, T., Torigoe, S., Okada, S., Mukai, T., Yamanishi, K. (1994) Human herpesvirus 7: another causal agent for roseola (exanthema subitum). J. Pediatr. 125, 1-5.
5. Drago, F., Ranieri, E., Malaguti, F, Losi, E., Rebora, A. (1997) Human herpesvirus 7 in pityriasis rosea. Lancet 349, 1367-1368.
6. Lasch, J. A., Klussmann, I. P., Krueger, G. R. (1996) Human herpesviruses 6 and 7. Basic principles and possible significance for dermatology. Hautarzt. 47, 341-350.
7. Torigoe, S., Koide, W., Yamada, M., Miyashiro, E., Tanaka, T. K., Yamanishi, K. (1996) Human herpesvirus 7 infection associated with central nervous system manifestations. J. Pediat. 129, 301-305.
8. Levy, J. A. (1997) Three new human herpesviruses (HHV 6, 7 and 8). Lancet 349, 558-563.
9. Wyatt, L. S., Frenkel, N. (1992) Human herpesvirus 7 is a constitutive inhabitant of adult human saliva. J. Virol. 66, 3206-3209.
10. + T-cell clones directed against human herpesvirus 6 (HHV-6), HHV-7, and human cytomegalovirus. J. Virol. 67, 6259-6264.
11. Yasukawa, M, Inoue, Y., Sada, E., Yakushijin, Y., Furukawa, M., Fujita, S. (1995) CD4 down-modulation by ganglioside and phorbol ester inhibits human herpesvirus 7 infection. J. Gen. Virol. 76, 2381-2385.
12. + T cells. J. Immunol. 152, 5768-5775.
13. Lusso, P., Secchiero, P., Crowley, R. W., Garzino-Demo, A., Berneman, Z. N., Gallo, R. C. (1994) CD4 is a critical component of the receptor for human herpesvirus 7: interference with human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 91, 3872-3876.
14. Flamand, L., Gosselin, J., D'Addadrio, M., Hiscot, J., Ablashi, D. V., Gallo, R. C., Menezes, J. (1991) Human herpesvirus 6 induces interleukin-1β and tumor necrosis factor alpha, but not interleukin-6, in peripheral blood mononuclear cell cultures. J. Virol. 65, 5105-5110.
15. Flamand, L., Gosselin, J., Stefanescu, I., Ablashi, D., Menezes, J. (1995) Immunosuppressive effect of human herpesvirus 6 on T-cell functions: suppression of interleukin-2 synthesis and cell proliferation. Blood 86, 1263-1271.
16. Flamand, L., Stefanescu, I., Menezes, J. (1996) Human herpesvirus 6 enhances natural killer cell cytotoxicity via IL-15. J. Clin. Invest. 97, 1373-1381.
17. Gosselin, J., Flamand, L., D'Addario, M., Hiscott, J., Stefanescu, I., Ablashi, D. V., Gallo, R. C., Menezes, J. (1992) Modulatory effects of Epstein-Barr, herpes simplex and human herpes-6 viral infections and co-infections on cytokine synthesis. A comparative study. J. Immunol. 149, 181-187.
18. Kirn, E., Kruger, E., Boehmer, H., Klussmann, P.J., Kruger, G. R. F. (1997) In vitro cytological effects of Human Herpesviruses 6 and 7: Immunohistological monitoring of apoptosis, differentiation and cell proliferation. Anticancer Res. 17, 4623-4632.
19. Paul, W. E., Seder, R. A. (1994) Lymphocyte responses and cytokines. Cell 76, 241-251.
20. Kishimoto, T., Taga, T., Shizuo, A. (1994) Cytokine signal transduction. Cell 76, 253-261.
21. Romagnani, S. (1997) The Th1/Th2 paradigm. Immunol. Today 18, 263-266.
22. Fresno, M., Kopf, M., Rivas, L. (1997) Cytokines and infectious diseases. Immunol. Today 18, 56-58.
23. Allen, J. E., Maizels, R. M. (1997) Th1-Th2: reliable pardigm or dangerous dogma. Immunol. Today 18, 387.
24. Atedzoé, B. N., Ahmad, A., Menezes, J. (1997) Enhancement of natural killer cell cytotoxicity by the human herpesvirus-7 via IL-15 induction. J. Immunol. 159, 4966-4972.
25. Berneman, Z. N., Ablashi, D. V., Li, G., Eger-Fletcher, M., Reitz, M. S., Hung, C. L., Brus, I., Komaroff, A. L., Gallo, R. C. (1992) Human herpesvirus 7 is a T-lymphotropic virus and is related to, but significantly different from, human herpesvirus 6 and human cytomegalovirus. Proc. Natl. Acd. Sci. USA 89, 10552-10556.
26. Bristol, L. A., Ruscetti, F. W., Brody, D. T., Durun, S. K. (1990) IL-1a induces expression of active transforming growth factor-β in non proliferating T cells via a post transcriptional mechanism. J. Immunol. 145, 4108-4114.
27. Ahmad, A., Menezes, J. (1997) Binding of the Epstein-Barr virus to human platelets causes the release of transforming growth factor-β. J. Immunol. 159, 3984-3988.
28. Chomczynski, P., Sacchi, N. (1987) Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-cholorophorm extraction. Anal. Biochem. 162, 156-159.
29. D'addadrio, M., Roulston, A., Wainberg, M. A., Hiscott, J. (1990) Coordinate enhancement of cytokine gene expression in human immunodeficiency virus type 1-infected promonocytic cells. J. Virol. 64, 6080-6089.
30. Smith, K. A. (1988) Interleukin-2: inception, impact and implications. Science 240, 1169-1176.
31. Vassalli, P. (1992) The pathophysiology of tumor necrosis factors. Ann. Rev. Immunol. 10, 411-452.
32. Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, A. L., Spiegelman, B. M. (1995) Increased adipose expression of tumor necrosis factor-α in human obesity and insulin resistance. J. Clin. Invest. 95, 2409-2415.
33. Duh, E. J., Maury, W. J., Folks, T. M., Fauci, A. S., Rabson, A. B. (1989) Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-κB sites in the long terminal repeat. Proc. Natl. Acad. Sci. USA 86, 5974-5978.
34. Farrar, M. A., Schreiber, R. D. (1993) The molecular cell biology of interferon-gamma and its receptor. Annu. Rev. Immunol. 11, 571-611.
35. Carson, W. E., Ross, M. E., Baiocchi, R. A., Manen, M. J., Boiani, N., Grabstein, K., Caligiuri, M. A. (1995) Endogenous production of interleukin 15 by activated human monocytes is critical for optimal production of interferon-γ by natural killer cells in vitro. J. Clin. Invest. 96, 2578-2582.
36. Tagaya, Y., Bramford, R. N., DeFillippis, A. P., Waldmann, T. A. (1996) IL-15: A plinotropic cytokine with diverse receptor/signalling pathways whose expression is controlled at multiple levels. Immunity 4, 329-336.
37. Letterio, J. J., Roberts, A. B. (1998) Regulation of immune response by TGF-β. Annu. Rev. Immunol. 16, 137-161.
38. Stravnezer, J. (1995) Regulation of antibody production and class switching by TGF-β. J. Immunol. 155, 1647-1651.
39. + T cells and NK cells. J. Exp. Med. 180, 1937-1942.
40. Allen, J. B., Wong, H. L., Guyre, P. M., Simon, G. L., Wahl, S. M. (1991) Association of circulating receptor FcγRIII-positive monocytes in AIDS patients with elevated levels of transforming growth factor-β. J. Clin. Invest. 87, 1773-1779.
41. Cayrol, C., Flemington, E. K. (1995) Identification of cellular target genes of the Epstein-Barr virus transactivator Zta: activation of transforming growth factor βigh3 (TGF-βigh3) and TGF-β1. J. Virol. 69, 4206-4212.
42. Schultz-Cherry, S., Hinshaw, V. S. (1996) Influenza virus neuraminidase activates latent transforming growth factor β. J. Virol. 70, 8624-8629.
43. Taga, T. (1997) Gp130 and the interleukin-6 family of cytokines. Annu. Rev. Immunol. 15, 797-819.
44. Thomas, X., Hirschauer, C., Troncy, J., Assouline, D., Joly, M. O., Fiere, D., Archimbaud, D. (1997) Serum interleukin-6 levels in adult acute myelogenous leukemia: relationship with disease characteristics and outcome. Leukemia Lymphoma 24, 291-300.
45. Sehgal, P. B., Helfgott, D. C., Santham, U., May, L. T. (1988) Regulation of the acute phase and immune response in viral disease. Enhanced expression of the beta 2-interferon/hepatocyte-stimulating factors/ interleukin-6 gene in virus infected human fibroblasts. J. Exp. Med. 167, 1951-1956.
46. Spriggs, M. K. (1996) One step ahead of the game: viral immunomodulatory molecules. Annu. Rev. Immunol. 14, 101-130.